Impact of Natalizumab Treatment on Fatigue, Mood, and Aspects of Cognition in Relapsing–Remitting Multiple Sclerosis

BACKGROUND/OBJECTIVE: Fatigue, cognitive, and affective disorders are relevant symptoms in multiple sclerosis (MS). The treatment with Natalizumab has a positive effect on physical disabilities in patients with relapsing–remitting MS (RRMS). Some studies describe improvements in cognition and fatigu...

Descripción completa

Detalles Bibliográficos
Autores principales: Kunkel, Annett, Fischer, Martin, Faiss, Judith, Dähne, Doreen, Köhler, Wolfgang, Faiss, Jürgen H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2015
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4426783/
https://www.ncbi.nlm.nih.gov/pubmed/26029156
http://dx.doi.org/10.3389/fneur.2015.00097

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4426783/
https://www.ncbi.nlm.nih.gov/pubmed/26029156
http://dx.doi.org/10.3389/fneur.2015.00097

Ejemplares similares